Sterling Capital Management »

Ocuphire Pharma shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $772 188 4.11

More positions owned by Sterling Capital Management

Rreef Core Plus Residential Fu LP
Vanguard S&p 500 Etf Etf (VOO)
NVIDIA Corporation (NVDA)
Manulife Co-investment Partner LP
Microsoft Corporation (MSFT)
Apple (AAPL)
Tq Db Pension Priv Inv Adm LP
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
JPMorgan Chase & Co. (JPM)
Charles Schwab Corporation (SCHW)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Amazon (AMZN)
Analog Devices (ADI)

View all positions for Sterling Capital Management

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
BlackRock
Balyasny Asset Management
Nantahala Capital Management
Vanguard Capital Management
Boxer Capital Management
Trails Edge Capital Partners
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Marshall Wace
ADAR1 Capital Management
Goldman Sachs Group
Woodline Partners

View all funds holding Ocuphire Pharma